From Nasdaq:

A federal judge dismissed a lawsuit by a startup against Apple for monopolizing heart rate monitoring apps for the Apple Watch. AliveCor accused Apple of violating antitrust law, but Apple’s ability to make improvements for the device was confirmed. AliveCor will appeal and is still litigating separate patent claims against Apple. The decision is being temporarily kept under seal.

Apple accused of “updating” the heart rate algorithm for its watches to prevent third parties from offering competing apps. AliveCor claimed Apple led it to believe in collaboration on heart-monitoring technology, then copied its ideas. Apple refuted wrongdoing and maintained that competitors have no right to dictate design decisions. AliveCor has developed KardiaBand, a wristband for the Apple Watch capable of an electrocardiogram (ECG)

In Oakland, California, U.S. District Judge Jeffrey White ruled against AliveCor, a Mountain View, California-based developer that claimed Apple “concentrated campaign(ed) to corner the market for heartrate analysis. Apple said the lawsuit challenged its ability to make improvements to the Apple Watch. The decision is temporarily under seal but will be appealed by AliveCor. Apple is also facing separate patent infringement claims from AliveCor.



Read more: Apple beats AliveCor lawsuit over heart-rate apps for Apple Watch